Matthew Kaplan
Stock Analyst
(n/a)
# 4,633
Out of 4,641 analysts
25
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $12.13 | +341.06% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $23.13 | +72.94% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $11.08 | +170.76% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $5.58 | +52.33% | 4 | Aug 3, 2023 | |
| UTHR United Therapeutics | Maintains: Buy | $256 → $268 | $352.58 | -23.99% | 8 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $13.22 | +21.03% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $3.52 | +30,326.14% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.37 | +6,191.03% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $5.48 | +831.51% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $12.30 | +30.08% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $1.88 | +2,293.62% | 1 | Jan 22, 2020 |
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $12.13
Upside: +341.06%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $23.13
Upside: +72.94%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $11.08
Upside: +170.76%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $5.58
Upside: +52.33%
United Therapeutics
Aug 3, 2023
Maintains: Buy
Price Target: $256 → $268
Current: $352.58
Upside: -23.99%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $13.22
Upside: +21.03%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $3.52
Upside: +30,326.14%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.37
Upside: +6,191.03%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $5.48
Upside: +831.51%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $12.30
Upside: +30.08%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $1.88
Upside: +2,293.62%